Pere Domingo

39PUBLICATIONS
158CO-AUTHORS
Separation technologiesCardiology (incl. cardiovascular diseases)Neural engineeringNutritional epidemiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jun 12, 2026
Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile.

|Jun 01, 2026
Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.

|Apr 27, 2026
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.

|Mar 04, 2026
Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.

Francesc Català-Moll, Carlos Blázquez-Bondia, Judit Farré-Badia

|Dec 30, 2025
Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration.

Alisa Timiryasova, Lauren Greenberg, Pere Domingo

|Jul 29, 2025
Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions.

Marta Giralt, Pere Domingo, Tania Quesada-López

Pageof 7

Frequent Collaborators

6 joint publications

Juan Berenguer

4 joint publications

Juliana Reyes-Urueña

4 joint publications

Daniel Kwakye Nomah

4 joint publications

Josep M Llibre